Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
Amat-Santos IJ, Sánchez-Luna JP, Abu-Assi E, Melendo-Viu M, Cruz-Gonzalez I, Nombela-Franco L, Muñoz-Garcí AJ, Blas SG, de la Torre Hernandez JM, Romaguera R, Sánchez-Recalde Á, Diez-Gil JL, Lopez-Otero D, Gheorge L, Ibáñez B, Iñiguez-Romo A, Raposeiras-Roubín S; Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) Investigators. Amat-Santos IJ, et al. Among authors: de la torre hernandez jm. Eur J Heart Fail. 2022 Mar;24(3):581-588. doi: 10.1002/ejhf.2370. Epub 2021 Nov 9. Eur J Heart Fail. 2022. PMID: 34693613 Free article. Clinical Trial.
[Update in interventional cardiology].
de la Torre Hernández JM, Díaz Fernández JF, Tenas MS, Ruigómez JG. de la Torre Hernández JM, et al. Rev Esp Cardiol. 2011;64 Suppl 1:13-9. doi: 10.1016/S0300-8932(11)70003-3. Rev Esp Cardiol. 2011. PMID: 21276486 Free article. Review. Spanish.
Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study.
de la Torre Hernandez JM, Hernández Hernandez F, Alfonso F, Rumoroso JR, Lopez-Palop R, Sadaba M, Carrillo P, Rondan J, Lozano I, Ruiz Nodar JM, Baz JA, Fernandez Nofrerias E, Pajin F, Garcia Camarero T, Gutierrez H; LITRO Study Group (Spanish Working Group on Interventional Cardiology). de la Torre Hernandez JM, et al. Among authors: hernandez hernandez f. J Am Coll Cardiol. 2011 Jul 19;58(4):351-8. doi: 10.1016/j.jacc.2011.02.064. J Am Coll Cardiol. 2011. PMID: 21757111 Free article. Clinical Trial.
Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry).
De la Torre Hernandez JM, Alfonso F, Sanchez Recalde A, Jimenez Navarro MF, Perez de Prado A, Hernandez F, Abdul-Jawad Altisent O, Roura G, Garcia Camarero T, Elizaga J, Rivero F, Gimeno F, Calviño R, Moreu J, Bosa F, Rumoroso JR, Bullones JA, Gallardo A, Fernandez Diaz JA, Ruiz Arroyo JR, Aragon V, Masotti M; ESTROFA-LM Study Group. De la Torre Hernandez JM, et al. Among authors: hernandez f. Am J Cardiol. 2013 Mar 1;111(5):676-83. doi: 10.1016/j.amjcard.2012.11.019. Epub 2012 Dec 27. Am J Cardiol. 2013. PMID: 23273715 Clinical Trial.
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Pérez de Prado A, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Ibanez B, et al. Among authors: de la torre hernandez jm, hernandez antolin r. Circulation. 2013 Oct 1;128(14):1495-503. doi: 10.1161/CIRCULATIONAHA.113.003653. Epub 2013 Sep 3. Circulation. 2013. PMID: 24002794 Clinical Trial.
A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly).
de Belder A, de la Torre Hernandez JM, Lopez-Palop R, O'Kane P, Hernandez Hernandez F, Strange J, Gimeno F, Cotton J, Diaz Fernandez JF, Carrillo Saez P, Thomas M, Pinar E, Curzen N, Baz JA, Cooter N, Lozano I, Skipper N, Robinson D, Hildick-Smith D; XIMA Investigators. de Belder A, et al. Among authors: de la torre hernandez jm, hernandez hernandez f. J Am Coll Cardiol. 2014 Apr 15;63(14):1371-5. doi: 10.1016/j.jacc.2013.10.053. Epub 2013 Nov 21. J Am Coll Cardiol. 2014. PMID: 24216285 Free article. Clinical Trial.
Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries.
de la Torre Hernandez JM, Baz Alonso JA, Gómez Hospital JA, Alfonso Manterola F, Garcia Camarero T, Gimeno de Carlos F, Roura Ferrer G, Recalde AS, Martínez-Luengas IL, Gomez Lara J, Hernandez Hernandez F, Pérez-Vizcayno MJ, Cequier Fillat A, Perez de Prado A, Gonzalez-Trevilla AA, Jimenez Navarro MF, Mauri Ferre J, Fernandez Diaz JA, Pinar Bermudez E, Zueco Gil J; IVUS-TRONCO-ICP Spanish study. de la Torre Hernandez JM, et al. Among authors: hernandez hernandez f. JACC Cardiovasc Interv. 2014 Mar;7(3):244-54. doi: 10.1016/j.jcin.2013.09.014. JACC Cardiovasc Interv. 2014. PMID: 24650399 Free article.
Effectiveness and safety beyond 10 years of percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
de la Torre Hernandez JM, Masotti Centol M, Lerena Saenz P, Sánchez Recalde Á, Gimeno de Carlos F, Piñón Esteban P, Fernandez Rodriguez D, Sitges Carreño M, Sabate Tenas M, Zueco Gil J. de la Torre Hernandez JM, et al. Rev Esp Cardiol (Engl Ed). 2014 May;67(5):353-8. doi: 10.1016/j.rec.2013.09.003. Epub 2013 Dec 4. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774727
Update on interventional cardiology.
de la Torre Hernández JM, Díaz Fernández JF, Sabaté Tenas M, Goicolea Ruigomez J. de la Torre Hernández JM, et al. Rev Esp Cardiol (Engl Ed). 2013 Apr;66(4):282-9. doi: 10.1016/j.rec.2012.10.017. Epub 2013 Jan 24. Rev Esp Cardiol (Engl Ed). 2013. PMID: 24775618 Review.
Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".
Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, de Prado AP, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Ibanez B, et al. Among authors: de prado ap, de la torre hernandez jm, hernandez antolin r. Circulation. 2014 Jul 15;130(3):e19-20. doi: 10.1161/CIRCULATIONAHA.114.009352. Circulation. 2014. PMID: 25024129 No abstract available.
200 results